Pauline Baumlin is a Senior Clinical Scientist in Hematology at Roche, where they lead clinical science efforts for bispecific molecules and contributed to successful filings for novel cancer therapies. From 2021 to 2024, Pauline played a key role in various clinical trial phases, protocol development, and interactions with health authorities, including presenting a scientific abstract at ASH 2023. Previously, Pauline held positions in data science, pharmacovigilance, and clinical research, and they have a Master's degree in clinical trials along with a PharmD from Université de Pharmacie in Toulouse. With extensive experience in the pharmaceutical industry, Pauline has actively contributed to multiple international scientific publications and congresses.
This person is not in the org chart
This person is not in any teams
This person is not in any offices